Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000770509 | SCV000901954 | uncertain significance | Cardiomyopathy | 2015-12-10 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000770509 | SCV001347701 | likely benign | Cardiomyopathy | 2018-11-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001410310 | SCV001612355 | likely benign | Hypertrophic cardiomyopathy 11; Dilated cardiomyopathy 1R; Atrial septal defect 5 | 2021-03-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002388391 | SCV002699947 | likely benign | Cardiovascular phenotype | 2022-01-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003999944 | SCV004844805 | likely benign | Hypertrophic cardiomyopathy | 2023-12-18 | criteria provided, single submitter | clinical testing |